Hormone replacement therapy may lower chance of developing Alzheimer’s in women with high-risk gene
- Menopause drug aids better memory, cognitive function and brain volumes
- People with two copies of APOE4 are up to 15% more likely to get Alzheimer’s
- Those with gene may start having symptoms ten years earlier than average
Hormone replacement therapy may prevent Alzheimer’s in high-risk women, a study suggests.
Taking the menopause drug was linked with better memory, cognitive function and larger brain volumes in later life in women carrying a gene called APOE4.
People with two copies of the gene are up to 15 per cent more likely to get Alzheimer’s and may start having symptoms ten years earlier than average.
This makes APOE4 the…